Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

DURECT Corp (NASDAQ:DRRX)

1.01
Delayed Data
As of Feb 17
 +0.0223 / +2.26%
Today’s Change
0.97
Today|||52-Week Range
2.00
-24.63%
Year-to-Date
No recent news for DURECT Corp.

Today’s Trading

Previous close0.99
Today’s open1.07
Day’s range0.98 - 1.07
Volume280,952
Average volume (3 months)503,614
Market cap$140.0M
Dividend yield--
Data as of 3:59pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)+5.00%
Earnings growth (this year)-38.60%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-1.43%
P/E ratioNM
Price/Sales13.70
Price/Book8.27

Competitors

 Today’s
change
Today’s
% change
IMDZImmune Design Corp-0.25-4.35%
OCXOncoCyte Corp+0.15+3.19%
FBIOFortress Biotech Inc+0.01+0.35%
ACRXAcelRx Pharmaceutica...0.000.00%
Data as of 4:00pm ET, 02/17/2017

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$19.1M
Annual profit (last year)-$22.7M
Net profit margin-118.51%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Scientific Officer
Felix Theeuwes
President, Chief Executive Officer &
Director
James E. Brown
Corporate headquarters
Cupertino, California

Forecasts


Search for Jobs